img

Global Vaginal Anti Infectives Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaginal Anti Infectives Market Research Report 2024

Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
According to Mr Accuracy reports’s new survey, global Vaginal Anti Infectives market is projected to reach US$ 4356.5 million in 2029, increasing from US$ 3120 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vaginal Anti Infectives market research.
Key manufacturers engaged in the Vaginal Anti Infectives industry include Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Vaginal Anti Infectives were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Vaginal Anti Infectives market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaginal Anti Infectives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Segment by Type
Oral
Ointment

Segment by Application


Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Vaginal Anti Infectives report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Vaginal Anti Infectives Market Overview
1.1 Product Overview and Scope of Vaginal Anti Infectives
1.2 Vaginal Anti Infectives Segment by Type
1.2.1 Global Vaginal Anti Infectives Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Ointment
1.3 Vaginal Anti Infectives Segment by Application
1.3.1 Global Vaginal Anti Infectives Market Value by Application: (2024-2034)
1.3.2 Bacterial Vaginitis
1.3.3 Trichomonal Vaginitis
1.3.4 Candida Vaginitis
1.4 Global Vaginal Anti Infectives Market Size Estimates and Forecasts
1.4.1 Global Vaginal Anti Infectives Revenue 2018-2029
1.4.2 Global Vaginal Anti Infectives Sales 2018-2029
1.4.3 Global Vaginal Anti Infectives Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vaginal Anti Infectives Market Competition by Manufacturers
2.1 Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2018-2024)
2.2 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Vaginal Anti Infectives Average Price by Manufacturers (2018-2024)
2.4 Global Vaginal Anti Infectives Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Vaginal Anti Infectives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaginal Anti Infectives, Product Type & Application
2.7 Vaginal Anti Infectives Market Competitive Situation and Trends
2.7.1 Vaginal Anti Infectives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
2.7.3 Global Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaginal Anti Infectives Retrospective Market Scenario by Region
3.1 Global Vaginal Anti Infectives Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vaginal Anti Infectives Global Vaginal Anti Infectives Sales by Region: 2018-2029
3.2.1 Global Vaginal Anti Infectives Sales by Region: 2018-2024
3.2.2 Global Vaginal Anti Infectives Sales by Region: 2024-2029
3.3 Global Vaginal Anti Infectives Global Vaginal Anti Infectives Revenue by Region: 2018-2029
3.3.1 Global Vaginal Anti Infectives Revenue by Region: 2018-2024
3.3.2 Global Vaginal Anti Infectives Revenue by Region: 2024-2029
3.4 North America Vaginal Anti Infectives Market Facts & Figures by Country
3.4.1 North America Vaginal Anti Infectives Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vaginal Anti Infectives Sales by Country (2018-2029)
3.4.3 North America Vaginal Anti Infectives Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaginal Anti Infectives Market Facts & Figures by Country
3.5.1 Europe Vaginal Anti Infectives Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vaginal Anti Infectives Sales by Country (2018-2029)
3.5.3 Europe Vaginal Anti Infectives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaginal Anti Infectives Market Facts & Figures by Country
3.6.1 Asia Pacific Vaginal Anti Infectives Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vaginal Anti Infectives Sales by Country (2018-2029)
3.6.3 Asia Pacific Vaginal Anti Infectives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaginal Anti Infectives Market Facts & Figures by Country
3.7.1 Latin America Vaginal Anti Infectives Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vaginal Anti Infectives Sales by Country (2018-2029)
3.7.3 Latin America Vaginal Anti Infectives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaginal Anti Infectives Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaginal Anti Infectives Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vaginal Anti Infectives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vaginal Anti Infectives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaginal Anti Infectives Sales by Type (2018-2029)
4.1.1 Global Vaginal Anti Infectives Sales by Type (2018-2024)
4.1.2 Global Vaginal Anti Infectives Sales by Type (2024-2029)
4.1.3 Global Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
4.2 Global Vaginal Anti Infectives Revenue by Type (2018-2029)
4.2.1 Global Vaginal Anti Infectives Revenue by Type (2018-2024)
4.2.2 Global Vaginal Anti Infectives Revenue by Type (2024-2029)
4.2.3 Global Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
4.3 Global Vaginal Anti Infectives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vaginal Anti Infectives Sales by Application (2018-2029)
5.1.1 Global Vaginal Anti Infectives Sales by Application (2018-2024)
5.1.2 Global Vaginal Anti Infectives Sales by Application (2024-2029)
5.1.3 Global Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
5.2 Global Vaginal Anti Infectives Revenue by Application (2018-2029)
5.2.1 Global Vaginal Anti Infectives Revenue by Application (2018-2024)
5.2.2 Global Vaginal Anti Infectives Revenue by Application (2024-2029)
5.2.3 Global Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
5.3 Global Vaginal Anti Infectives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Inc Vaginal Anti Infectives Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Mylan N.V
6.2.1 Mylan N.V Corporation Information
6.2.2 Mylan N.V Description and Business Overview
6.2.3 Mylan N.V Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Mylan N.V Vaginal Anti Infectives Product Portfolio
6.2.5 Mylan N.V Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Novartis AG Vaginal Anti Infectives Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Hikma Pharmaceuticals plc
6.4.1 Hikma Pharmaceuticals plc Corporation Information
6.4.2 Hikma Pharmaceuticals plc Description and Business Overview
6.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Portfolio
6.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Aurobindo Pharma Vaginal Anti Infectives Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.6.4 AbbVie Inc Vaginal Anti Infectives Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Melinta Therapeutics, Inc
6.6.1 Melinta Therapeutics, Inc Corporation Information
6.6.2 Melinta Therapeutics, Inc Description and Business Overview
6.6.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Portfolio
6.7.5 Melinta Therapeutics, Inc Recent Developments/Updates
6.8 Bristol-Myers Squibb Company
6.8.1 Bristol-Myers Squibb Company Corporation Information
6.8.2 Bristol-Myers Squibb Company Description and Business Overview
6.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Portfolio
6.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.9 GSK plc
6.9.1 GSK plc Corporation Information
6.9.2 GSK plc Description and Business Overview
6.9.3 GSK plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.9.4 GSK plc Vaginal Anti Infectives Product Portfolio
6.9.5 GSK plc Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Corporation Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Bayer AG Vaginal Anti Infectives Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Vaginal Anti Infectives Description and Business Overview
6.11.3 Lupin Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Lupin Vaginal Anti Infectives Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 Perrigo Company plc
6.12.1 Perrigo Company plc Corporation Information
6.12.2 Perrigo Company plc Vaginal Anti Infectives Description and Business Overview
6.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Perrigo Company plc Vaginal Anti Infectives Product Portfolio
6.12.5 Perrigo Company plc Recent Developments/Updates
6.13 Bayer
6.13.1 Bayer Corporation Information
6.13.2 Bayer Vaginal Anti Infectives Description and Business Overview
6.13.3 Bayer Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Bayer Vaginal Anti Infectives Product Portfolio
6.13.5 Bayer Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Vaginal Anti Infectives Description and Business Overview
6.14.3 Sanofi Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Sanofi Vaginal Anti Infectives Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Scynexis
6.15.1 Scynexis Corporation Information
6.15.2 Scynexis Vaginal Anti Infectives Description and Business Overview
6.15.3 Scynexis Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Scynexis Vaginal Anti Infectives Product Portfolio
6.15.5 Scynexis Recent Developments/Updates
6.16 Bausch Health Companies Inc
6.16.1 Bausch Health Companies Inc Corporation Information
6.16.2 Bausch Health Companies Inc Vaginal Anti Infectives Description and Business Overview
6.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Bausch Health Companies Inc Vaginal Anti Infectives Product Portfolio
6.16.5 Bausch Health Companies Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaginal Anti Infectives Industry Chain Analysis
7.2 Vaginal Anti Infectives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaginal Anti Infectives Production Mode & Process
7.4 Vaginal Anti Infectives Sales and Marketing
7.4.1 Vaginal Anti Infectives Sales Channels
7.4.2 Vaginal Anti Infectives Distributors
7.5 Vaginal Anti Infectives Customers
8 Vaginal Anti Infectives Market Dynamics
8.1 Vaginal Anti Infectives Industry Trends
8.2 Vaginal Anti Infectives Market Drivers
8.3 Vaginal Anti Infectives Market Challenges
8.4 Vaginal Anti Infectives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaginal Anti Infectives Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Vaginal Anti Infectives Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Vaginal Anti Infectives Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vaginal Anti Infectives Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Vaginal Anti Infectives Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Vaginal Anti Infectives Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Vaginal Anti Infectives, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Vaginal Anti Infectives, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaginal Anti Infectives, Product Type & Application
Table 12. Global Key Manufacturers of Vaginal Anti Infectives, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaginal Anti Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaginal Anti Infectives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vaginal Anti Infectives Sales by Region (2018-2024) & (K Units)
Table 18. Global Vaginal Anti Infectives Sales Market Share by Region (2018-2024)
Table 19. Global Vaginal Anti Infectives Sales by Region (2024-2029) & (K Units)
Table 20. Global Vaginal Anti Infectives Sales Market Share by Region (2024-2029)
Table 21. Global Vaginal Anti Infectives Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Vaginal Anti Infectives Revenue Market Share by Region (2018-2024)
Table 23. Global Vaginal Anti Infectives Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vaginal Anti Infectives Revenue Market Share by Region (2024-2029)
Table 25. North America Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 27. North America Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 28. North America Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 32. Europe Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 33. Europe Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vaginal Anti Infectives Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vaginal Anti Infectives Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Vaginal Anti Infectives Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Vaginal Anti Infectives Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Vaginal Anti Infectives Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vaginal Anti Infectives Sales (K Units) by Type (2018-2024)
Table 51. Global Vaginal Anti Infectives Sales (K Units) by Type (2024-2029)
Table 52. Global Vaginal Anti Infectives Sales Market Share by Type (2018-2024)
Table 53. Global Vaginal Anti Infectives Sales Market Share by Type (2024-2029)
Table 54. Global Vaginal Anti Infectives Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Vaginal Anti Infectives Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vaginal Anti Infectives Revenue Market Share by Type (2018-2024)
Table 57. Global Vaginal Anti Infectives Revenue Market Share by Type (2024-2029)
Table 58. Global Vaginal Anti Infectives Price (US$/Unit) by Type (2018-2024)
Table 59. Global Vaginal Anti Infectives Price (US$/Unit) by Type (2024-2029)
Table 60. Global Vaginal Anti Infectives Sales (K Units) by Application (2018-2024)
Table 61. Global Vaginal Anti Infectives Sales (K Units) by Application (2024-2029)
Table 62. Global Vaginal Anti Infectives Sales Market Share by Application (2018-2024)
Table 63. Global Vaginal Anti Infectives Sales Market Share by Application (2024-2029)
Table 64. Global Vaginal Anti Infectives Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Vaginal Anti Infectives Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vaginal Anti Infectives Revenue Market Share by Application (2018-2024)
Table 67. Global Vaginal Anti Infectives Revenue Market Share by Application (2024-2029)
Table 68. Global Vaginal Anti Infectives Price (US$/Unit) by Application (2018-2024)
Table 69. Global Vaginal Anti Infectives Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Inc Corporation Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Inc Vaginal Anti Infectives Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Mylan N.V Corporation Information
Table 76. Mylan N.V Description and Business Overview
Table 77. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Mylan N.V Vaginal Anti Infectives Product
Table 79. Mylan N.V Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Novartis AG Vaginal Anti Infectives Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Hikma Pharmaceuticals plc Corporation Information
Table 86. Hikma Pharmaceuticals plc Description and Business Overview
Table 87. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product
Table 89. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 90. Aurobindo Pharma Corporation Information
Table 91. Aurobindo Pharma Description and Business Overview
Table 92. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Aurobindo Pharma Vaginal Anti Infectives Product
Table 94. Aurobindo Pharma Recent Developments/Updates
Table 95. AbbVie Inc Corporation Information
Table 96. AbbVie Inc Description and Business Overview
Table 97. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. AbbVie Inc Vaginal Anti Infectives Product
Table 99. AbbVie Inc Recent Developments/Updates
Table 100. Melinta Therapeutics, Inc Corporation Information
Table 101. Melinta Therapeutics, Inc Description and Business Overview
Table 102. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Melinta Therapeutics, Inc Vaginal Anti Infectives Product
Table 104. Melinta Therapeutics, Inc Recent Developments/Updates
Table 105. Bristol-Myers Squibb Company Corporation Information
Table 106. Bristol-Myers Squibb Company Description and Business Overview
Table 107. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bristol-Myers Squibb Company Vaginal Anti Infectives Product
Table 109. Bristol-Myers Squibb Company Recent Developments/Updates
Table 110. GSK plc Corporation Information
Table 111. GSK plc Description and Business Overview
Table 112. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. GSK plc Vaginal Anti Infectives Product
Table 114. GSK plc Recent Developments/Updates
Table 115. Bayer AG Corporation Information
Table 116. Bayer AG Description and Business Overview
Table 117. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Bayer AG Vaginal Anti Infectives Product
Table 119. Bayer AG Recent Developments/Updates
Table 120. Lupin Corporation Information
Table 121. Lupin Description and Business Overview
Table 122. Lupin Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Lupin Vaginal Anti Infectives Product
Table 124. Lupin Recent Developments/Updates
Table 125. Perrigo Company plc Corporation Information
Table 126. Perrigo Company plc Description and Business Overview
Table 127. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Perrigo Company plc Vaginal Anti Infectives Product
Table 129. Perrigo Company plc Recent Developments/Updates
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Bayer Vaginal Anti Infectives Product
Table 134. Bayer Recent Developments/Updates
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Sanofi Vaginal Anti Infectives Product
Table 139. Sanofi Recent Developments/Updates
Table 140. Scynexis Corporation Information
Table 141. Scynexis Description and Business Overview
Table 142. Scynexis Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Scynexis Vaginal Anti Infectives Product
Table 144. Scynexis Recent Developments/Updates
Table 145. Bausch Health Companies Inc Corporation Information
Table 146. Bausch Health Companies Inc Description and Business Overview
Table 147. Bausch Health Companies Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Bausch Health Companies Inc Vaginal Anti Infectives Product
Table 149. Bausch Health Companies Inc Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Vaginal Anti Infectives Distributors List
Table 153. Vaginal Anti Infectives Customers List
Table 154. Vaginal Anti Infectives Market Trends
Table 155. Vaginal Anti Infectives Market Drivers
Table 156. Vaginal Anti Infectives Market Challenges
Table 157. Vaginal Anti Infectives Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaginal Anti Infectives
Figure 2. Global Vaginal Anti Infectives Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Vaginal Anti Infectives Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Ointment Product Picture
Figure 6. Global Vaginal Anti Infectives Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Vaginal Anti Infectives Market Share by Application in 2022 & 2029
Figure 8. Bacterial Vaginitis
Figure 9. Trichomonal Vaginitis
Figure 10. Candida Vaginitis
Figure 11. Global Vaginal Anti Infectives Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vaginal Anti Infectives Market Size (2018-2029) & (US$ Million)
Figure 13. Global Vaginal Anti Infectives Sales (2018-2029) & (K Units)
Figure 14. Global Vaginal Anti Infectives Average Price (US$/Unit) & (2018-2029)
Figure 15. Vaginal Anti Infectives Report Years Considered
Figure 16. Vaginal Anti Infectives Sales Share by Manufacturers in 2022
Figure 17. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Vaginal Anti Infectives Players: Market Share by Revenue in 2022
Figure 19. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Vaginal Anti Infectives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Vaginal Anti Infectives Sales Market Share by Country (2018-2029)
Figure 22. North America Vaginal Anti Infectives Revenue Market Share by Country (2018-2029)
Figure 23. United States Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Vaginal Anti Infectives Sales Market Share by Country (2018-2029)
Figure 26. Europe Vaginal Anti Infectives Revenue Market Share by Country (2018-2029)
Figure 27. Germany Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Vaginal Anti Infectives Revenue Market Share by Region (2018-2029)
Figure 34. China Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Vaginal Anti Infectives Sales Market Share by Country (2018-2029)
Figure 42. Latin America Vaginal Anti Infectives Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Vaginal Anti Infectives Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Vaginal Anti Infectives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Vaginal Anti Infectives by Type (2018-2029)
Figure 52. Global Revenue Market Share of Vaginal Anti Infectives by Type (2018-2029)
Figure 53. Global Vaginal Anti Infectives Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Vaginal Anti Infectives by Application (2018-2029)
Figure 55. Global Revenue Market Share of Vaginal Anti Infectives by Application (2018-2029)
Figure 56. Global Vaginal Anti Infectives Price (US$/Unit) by Application (2018-2029)
Figure 57. Vaginal Anti Infectives Value Chain
Figure 58. Vaginal Anti Infectives Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries